Sermorelin, explained

Sermorelin sits in a category of therapies that many people have heard of but few can define: it is a growth hormone secretagogue — specifically, a synthetic analog of growth hormone–releasing hormone (GHRH). Those two terms do a lot of work, so this guide unpacks them: what sermorelin actually is, how it differs from taking growth hormone directly, why that mechanistic difference matters, and what prescribed protocols generally look like.

What sermorelin is

GHRH is the hormone the hypothalamus uses to signal the pituitary gland — the small gland at the base of the brain that manufactures and releases growth hormone. Sermorelin is a synthetic peptide that reproduces the active portion of the GHRH chain: enough of the molecule to bind the same pituitary receptors and deliver the same “release” signal the body's own GHRH delivers.

“Secretagogue” means exactly what it sounds like: a substance that prompts the body to secrete something. Sermorelin does not add growth hormone from the outside. It signals the pituitary to produce and release the body's own.

How it differs from direct HGH

Direct human growth hormone (HGH) therapy supplies the finished hormone itself. The amount circulating is set by the amount injected — the pituitary is bypassed, and the body's own production machinery is not part of the equation. Levels rise because the hormone was put there.

Sermorelin works one step upstream. It stimulates the pituitary, and whatever growth hormone results is made and released by the gland itself. The medication supplies the signal; the body supplies the hormone. That is the entire distinction, and it is a meaningful one.

Why working with the body's own regulation matters

The body regulates growth hormone through feedback loops. When circulating levels rise, a counter-signal — somatostatin — tells the pituitary to ease off. Release is also naturally pulsatile: growth hormone arrives in bursts rather than a steady stream, with much of it concentrated during deep sleep.

Because sermorelin acts through the pituitary rather than around it, those regulatory checkpoints stay in the loop. Release remains pulsatile, and the somatostatin feedback brake still applies — the gland's own control system remains part of the process. With direct HGH, by contrast, the hormone enters circulation without passing through that control system at all.

To be clear about what this is and is not: that is a description of mechanism, not a claim that one approach is better or right for any particular person. Whether any growth-hormone-related therapy is appropriate — and which one — is a determination only a licensed provider can make, based on your health history and evaluation.

What protocols generally look like

Prescribed sermorelin protocols are typically built around a subcutaneous injection — a small injection under the skin, of the kind many peptide therapies use. Evening administration is common in prescribed protocols, and the reason is the physiology described above: the body's own growth hormone release is concentrated during sleep, and providers generally aim to work with that rhythm rather than against it.

Beyond those generalities, the specifics — dose, frequency, timing, duration, and whether sermorelin is appropriate for you at all — are individualized decisions made by the prescribing provider. There is no universal protocol, and nothing in this article should be read as a dosing recommendation. If a source online offers you a one-size-fits-all sermorelin regimen without a provider involved, treat that as a warning sign, not a shortcut.

Compounding status: what to know

Sermorelin is available today through compounding pharmacies. At Peptivik, it is prepared for individual patients by state-licensed US 503A compounding pharmacies when prescribed by a licensed provider. Compounded medications are not FDA-approved and are not reviewed by the FDA for safety or efficacy. The pharmacies preparing them are subject to state board of pharmacy oversight and USP sterility, endotoxin, and potency standards — a different regulatory lane than FDA premarket review, and one you should expect any honest platform to disclose plainly.

Questions worth asking a provider

• Whether a GHRH analog fits your health history and goals in the first place.
• What evaluation or monitoring they would recommend before and during treatment.
• How they think about sermorelin versus other approaches, and why.
• What administration and timing would look like for you specifically — including whether evening dosing applies in your case.

The bottom line

Sermorelin is a signal, not a replacement: a GHRH analog that asks the pituitary to release the body's own growth hormone, with the body's own feedback loops still in play. That mechanism is what separates it from direct HGH — and, as with any prescription therapy, whether it makes sense for you is a decision that belongs with a licensed provider.